Orphan designation: 2-(2-{[2-(1H-benzimidazol-2-yl)ethyl]amino}ethyl)-N-[(3-fluoropyridine-2-yl)methyl]-1,3-oxazole-4-carboxamide trihydrochloride, Treatment of beta-thalassaemia intermedia and major

2019 ◽  
Author(s):  
Sign in / Sign up

Export Citation Format

Share Document